Stockholders’ Equity | Note 6. Stockholders’ Equity The following are changes in stockholders’ equity for the nine months ended September 30, 2023 and 2024: Schedule of Changes in Stockholders' Equity Additional Common Stock paid in Accumulated Shares Amount Capital (Deficit) Total Balance December 31, 2022 12,934,741 $ - $ 60,905,000 $ (57,972,000 ) $ 2,933,000 Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding 165,779 - (18,000 ) - (18,000 ) Equity-based compensation expense - - 514,000 - 514,000 Cash settlement of equity-based compensation - - (24,000 ) - (24,000 ) Issuance of stock for services 4,094 - 11,000 - 11,000 Net loss - - - (2,123,000 ) (2,123,000 ) Balance September 30, 2023 13,104,614 $ - $ 61,388,000 $ (60,095,000 ) $ 1,293,000 Additional Common Stock paid in Accumulated Shares Amount Capital (Deficit) Total Balance December 31, 2023 14,420,105 $ - $ 63,299,000 $ (60,796,000 ) $ 2,503,000 Balance 14,420,105 $ - $ 63,299,000 $ (60,796,000 ) $ 2,503,000 Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding 201,859 - (20,000 ) - (20,000 ) Equity-based compensation expense - - 757,000 - 757,000 Conversion of debt and interest (Note 5) 124,208 - 136,000 - 136,000 Net loss - - - (1,973,000 ) (1,973,000 ) Balance September 30, 2024 14,746,172 $ - $ 64,172,000 $ (62,769,000 ) $ 1,403,000 Balance 14,746,172 $ - $ 64,172,000 $ (62,769,000 ) $ 1,403,000 Warrants During the nine months ended September 30, 2024, 122,739 9.10 Equity Incentive Plan Through 2022, the Company issued equity awards under the 2015 Equity Incentive Plan (the “2015 Plan”) and outside the Plan. In June 2023, the Company’s stockholders adopted the 2023 Equity Incentive Plan (the “2023 Plan”), reserving 650,000 650,000 1,300,000 As of September 30, 2024, the Company has $ 545,000 Stock Options The following is a summary of stock option activity for the nine months ended September 30, 2024: Schedule of Stock Options Activity Number of Options Weighted average exercise price per share Remaining term in years Outstanding on December 31, 2023 587,091 $ 6.50 3.6 Issued 238,482 $ 2.05 8.0 Expired (71,930 ) $ 7.95 Outstanding on September 30, 2024 753,643 $ 4.95 5.3 Exercisable, September 30, 2024 540,681 $ 5.98 3.8 The fair value of the options issued was calculated using the Black-Scholes option pricing model, based on the following: Schedule of Fair Value of Options Using Black-Sholes Option Pricing Model 2024 Expected term (in years) 8.0 Expected volatility 93.5 % Risk-free interest rate 4.2 % Expected dividends $ - Weighted average grant date fair value per share $ 1.77 Restricted Stock The following is a summary of restricted stock award and restricted stock unit activity for the nine months ended September 30, 2024: Schedule of Restricted Stock Award and Restricted Stock Unit Activity Number of shares Weighted average grant date fair value Unvested at January 1, 2024 32,606 $ 4.82 Granted 65,000 $ 1.73 Vested (10,733 ) $ 5.58 Unvested at September 30, 2024 86,873 $ 2.41 Performance Share Units During 2023 and 2024, the Company issued performance share units (“PSUs”) that represented shares potentially issuable based upon Company and individual performance in the years of issuance. The following table summarizes the activity for the Company’s unvested PSUs for the nine months ended September 30, 2024: Schedule of Performance Stock Unit Activity Number of shares Weighted average grant date fair value Unvested at January 1, 2024 63,888 $ 1.70 Granted 429,844 $ 1.22 Vested (55,217 ) $ 1.15 Unvested and expected to vest at September 30, 2024 438,515 $ 1.20 In February 2023, the unvested awards issued and outstanding for individual performance under the 2022 PSU program were modified to cash-settle the original grant-date fair value of approximately $ 80,000 56,000 24,000 71,000 26,000 64,000 The Company adopted a 2024 PSU program in March 2024, granting approximately 430,000 79,000 289,000 |